A detailed history of Exencial Wealth Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Exencial Wealth Advisors, LLC holds 18,178 shares of AMGN stock, worth $5.09 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
18,178
Previous 18,838 3.5%
Holding current value
$5.09 Million
Previous $5.89 Million 0.48%
% of portfolio
0.22%
Previous 0.22%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$309.38 - $337.38 $204,190 - $222,670
-660 Reduced 3.5%
18,178 $5.86 Million
Q2 2024

Aug 12, 2024

SELL
$262.75 - $319.31 $289,550 - $351,879
-1,102 Reduced 5.53%
18,838 $5.89 Million
Q1 2024

May 10, 2024

BUY
$268.87 - $324.56 $70,981 - $85,683
264 Added 1.34%
19,940 $5.67 Million
Q4 2023

Feb 13, 2024

BUY
$255.7 - $288.46 $222,203 - $250,671
869 Added 4.62%
19,676 $5.67 Million
Q3 2023

Nov 08, 2023

SELL
$218.65 - $271.46 $85,054 - $105,597
-389 Reduced 2.03%
18,807 $5.05 Million
Q2 2023

Aug 10, 2023

BUY
$214.27 - $253.37 $264,194 - $312,405
1,233 Added 6.86%
19,196 $4.26 Million
Q1 2023

May 02, 2023

BUY
$225.79 - $275.2 $95,283 - $116,134
422 Added 2.41%
17,963 $4.34 Million
Q4 2022

Feb 14, 2023

BUY
$229.03 - $291.01 $438,363 - $556,993
1,914 Added 12.25%
17,541 $4.61 Million
Q3 2022

Nov 08, 2022

BUY
$224.46 - $253.15 $126,819 - $143,029
565 Added 3.75%
15,627 $3.52 Million
Q2 2022

Aug 11, 2022

BUY
$230.71 - $256.74 $8,766 - $9,756
38 Added 0.25%
15,062 $3.67 Million
Q1 2022

May 12, 2022

BUY
$219.27 - $242.57 $119,282 - $131,958
544 Added 3.76%
15,024 $3.63 Million
Q4 2021

Feb 10, 2022

BUY
$198.88 - $227.6 $113,560 - $129,959
571 Added 4.11%
14,480 $3.26 Million
Q3 2021

Nov 04, 2021

BUY
$212.27 - $248.7 $379,538 - $444,675
1,788 Added 14.75%
13,909 $2.96 Million
Q2 2021

Aug 16, 2021

SELL
$233.58 - $259.14 $507,102 - $562,592
-2,171 Reduced 15.19%
12,121 $2.96 Million
Q1 2021

May 06, 2021

BUY
$221.91 - $258.6 $521,710 - $607,968
2,351 Added 19.69%
14,292 $3.56 Million
Q4 2020

Feb 11, 2021

SELL
$216.38 - $257.67 $2.46 Million - $2.93 Million
-11,364 Reduced 48.76%
11,941 $2.75 Million
Q3 2020

Nov 13, 2020

BUY
$234.65 - $260.95 $2.68 Million - $2.98 Million
11,433 Added 96.3%
23,305 $5.92 Million
Q2 2020

Aug 17, 2020

BUY
$197.81 - $242.74 $1.82 Million - $2.23 Million
9,184 Added 341.67%
11,872 $2.8 Million
Q1 2020

May 15, 2020

BUY
$182.24 - $241.7 $19,681 - $26,103
108 Added 4.19%
2,688 $545,000
Q4 2019

Feb 14, 2020

SELL
$189.21 - $243.2 $7,568 - $9,728
-40 Reduced 1.53%
2,580 $622,000
Q3 2019

Nov 13, 2019

SELL
$174.11 - $208.62 $47,532 - $56,953
-273 Reduced 9.44%
2,620 $507,000
Q1 2019

May 08, 2019

SELL
$180.87 - $203.88 $14,107 - $15,902
-78 Reduced 2.63%
2,893 $550,000
Q4 2018

Feb 06, 2019

BUY
$178.4 - $208.25 $99,904 - $116,620
560 Added 23.23%
2,971 $578,000
Q3 2018

Nov 05, 2018

SELL
$185.29 - $208.89 $9,820 - $11,071
-53 Reduced 2.15%
2,411 $500,000
Q1 2018

May 09, 2018

BUY
$169.43 - $198.0 $34,055 - $39,798
201 Added 8.88%
2,464 $420,000
Q4 2017

Feb 09, 2018

SELL
$168.79 - $188.59 $4,557 - $5,091
-27 Reduced 1.18%
2,263 $394,000
Q3 2017

Nov 08, 2017

BUY
$167.29 - $191.0 $383,094 - $437,390
2,290
2,290 $427,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Exencial Wealth Advisors, LLC Portfolio

Follow Exencial Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exencial Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exencial Wealth Advisors, LLC with notifications on news.